Stay updated on Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.

Latest updates to the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a new page revision entry labeled v3.3.2 and removed the previous v3.2.0 from the history, reflecting internal versioning updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the government funding/operating status banner from the page header of the NCT04128501 record. The notice previously appeared at the top of the ClinicalTrials.gov record.SummaryDifference0.5%

- Check35 days agoChange DetectedNew screenshot shows a minor UI/layout update to the Record History page without altering the listed study data or version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedUpdate: Added October 2025 study status entries and date, removed April 2025 status.SummaryDifference1%

- Check63 days agoChange DetectedCore page content updated to include a funding-status notice and operating-status guidance, plus a version upgrade from v3.1.0 to v3.2.0.SummaryDifference11%

- Check71 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.3%

Stay in the know with updates to Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.